American Academy of Ophthalmology Meeting

CHICAGO – At the American Academy of Ophthalmology meeting, Jason Hsu, MD, discusses a study that found patients who were lost to follow-up after diabetic retinopathy treatment had better outcomes if they had received pan-retinal photocoagulation than anti-VEGF alone.

CHICAGO – At the American Academy of Ophthalmology meeting, Alex Huang, MD, PhD, of UCLA’s Doheny Eye Institute, details recent research regarding spaceflight-associated neuro-ocular syndrome and how ophthalmologists are using data to also gain insight into earth-bound eye diseases.

CHICAGO – At the American Academy of Ophthalmology meeting, John P. Berdahl, MD, discusses results from the phase 2 clinical trial of iDose (Glaukos), a microinvasive titanium implant that elutes travoprost over time to reduce intraocular pressure.

CHICAGO – Nathan Radcliffe, MD, discusses the benefits of the recently FDA approved iStent inject from Glaukos at the American Academy of Ophthalmology meeting.

CHICAGO – At the American Academy of Ophthalmology meeting, David Eichenbaum, MD, discusses the PALADIN study and the use of Iluvien (fluocinolone acetonide, Alimera Sciences) in a real-world diabetic macular edema population.

CHICAGO – William B. Trattler, MD, discusses the benefits of Dompé’s nerve growth factor Oxervate (cenegermin) for treating non-healing epithelial defects at the American Academy of Ophthalmology meeting.

CHICAGO At the American Academy of Ophthalmology meeting here, Bob Main, MS, CEO of Web Vision Technologies, discusses his company’s attempts to recruit visual testing companies to help it develop a multi-functional ophthalmic device, an all-in-one visual testing device, for the NASA space program.

CHICAGO — At the American Academy of Ophthalmology meeting here, Cynthia Matossian, MD, FACS, discusses ways to prevent different forms of embezzlement in medical practices.

CHICAGO — Steven Silverstein, MD, discusses pattern and flicker electrophysiology devices (Diopsys) for diagnosing, monitoring and treating patients with glaucoma and retinopathies at the American Academy of Ophthalmology meeting here.

CHICAGO — Minimally invasive corneal neurotization was successful in treating neurotrophic keratopathy, according to a speaker here.